Use of a common standard for comparison of insulin C-peptide measurements by different laboratories

A synthetic human C-peptide analogue has been used as a common standard for the comparison of insulin C-peptide measurements in seven assay systems in six laboratories. Even in terms of this common standard there was statistically significant numerical heterogeneity between laboratories for estimate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetologia 1980-03, Vol.18 (3), p.197-204
Hauptverfasser: Caygill, C P, Gaines Das, R E, Bangham, D R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 204
container_issue 3
container_start_page 197
container_title Diabetologia
container_volume 18
creator Caygill, C P
Gaines Das, R E
Bangham, D R
description A synthetic human C-peptide analogue has been used as a common standard for the comparison of insulin C-peptide measurements in seven assay systems in six laboratories. Even in terms of this common standard there was statistically significant numerical heterogeneity between laboratories for estimates of the C-peptide content of the same plasma samples. However, the consistency in ranking order of estimates of C-peptide in the plasma samples between laboratories suggests that laboratories are in most cases measuring at least similar immunoreactive constituents and that a reference plasma might prove useful in comparing results between laboratories. Until a more suitable reference material is available, the synthetic analogue, 64 formyllysine C-peptide, in ampoules coded 76/561, will be made available for research purposes.
doi_str_mv 10.1007/BF00251916
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75101336</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75101336</sourcerecordid><originalsourceid>FETCH-LOGICAL-c318t-d4b2b740d3c374c69abf81542d97c3e451e32fca6ccb2cad6125fd7bce322e803</originalsourceid><addsrcrecordid>eNpFkEtLxDAURoMo4zi6cS9k5UKo5tW0XergqDDgxgF3JY8biDRNTdqF_94OM-jqcg-Hb3EQuqbknhJSPTxtCGElbag8QUsqOCuIYPUpWhJCWUFr-XmOLnL-IoTwUsgFWkgmyqbmS2R2GXB0WGETQ4g9zqPqrUoWu5j2bFDJ55nPju_z1Pker4sBhtFbwAFUnhIE6MeM9Q-23jlI84c7pWNSY0we8iU6c6rLcHW8K7TbPH-sX4vt-8vb-nFbGE7rsbBCM10JYrnhlTCyUdrVtBTMNpXhIEoKnDmjpDGaGWUlZaWzlTYzZlATvkK3h90hxe8J8tgGnw10neohTrmtSkoo53IW7w6iSTHnBK4dkg8q_bSUtPui7X_RWb45rk46gP1Tjwn5L6urce8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75101336</pqid></control><display><type>article</type><title>Use of a common standard for comparison of insulin C-peptide measurements by different laboratories</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Caygill, C P ; Gaines Das, R E ; Bangham, D R</creator><creatorcontrib>Caygill, C P ; Gaines Das, R E ; Bangham, D R</creatorcontrib><description>A synthetic human C-peptide analogue has been used as a common standard for the comparison of insulin C-peptide measurements in seven assay systems in six laboratories. Even in terms of this common standard there was statistically significant numerical heterogeneity between laboratories for estimates of the C-peptide content of the same plasma samples. However, the consistency in ranking order of estimates of C-peptide in the plasma samples between laboratories suggests that laboratories are in most cases measuring at least similar immunoreactive constituents and that a reference plasma might prove useful in comparing results between laboratories. Until a more suitable reference material is available, the synthetic analogue, 64 formyllysine C-peptide, in ampoules coded 76/561, will be made available for research purposes.</description><identifier>ISSN: 0012-186X</identifier><identifier>EISSN: 1432-0428</identifier><identifier>DOI: 10.1007/BF00251916</identifier><identifier>PMID: 6245983</identifier><language>eng</language><publisher>Germany</publisher><subject>Adenoma, Islet Cell - blood ; C-Peptide - analogs &amp; derivatives ; C-Peptide - blood ; Diabetes Mellitus - blood ; Humans ; Pancreatic Neoplasms - blood ; Peptides - blood ; Proinsulin - blood ; Quality Control ; Radioimmunoassay - methods</subject><ispartof>Diabetologia, 1980-03, Vol.18 (3), p.197-204</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c318t-d4b2b740d3c374c69abf81542d97c3e451e32fca6ccb2cad6125fd7bce322e803</citedby><cites>FETCH-LOGICAL-c318t-d4b2b740d3c374c69abf81542d97c3e451e32fca6ccb2cad6125fd7bce322e803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6245983$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Caygill, C P</creatorcontrib><creatorcontrib>Gaines Das, R E</creatorcontrib><creatorcontrib>Bangham, D R</creatorcontrib><title>Use of a common standard for comparison of insulin C-peptide measurements by different laboratories</title><title>Diabetologia</title><addtitle>Diabetologia</addtitle><description>A synthetic human C-peptide analogue has been used as a common standard for the comparison of insulin C-peptide measurements in seven assay systems in six laboratories. Even in terms of this common standard there was statistically significant numerical heterogeneity between laboratories for estimates of the C-peptide content of the same plasma samples. However, the consistency in ranking order of estimates of C-peptide in the plasma samples between laboratories suggests that laboratories are in most cases measuring at least similar immunoreactive constituents and that a reference plasma might prove useful in comparing results between laboratories. Until a more suitable reference material is available, the synthetic analogue, 64 formyllysine C-peptide, in ampoules coded 76/561, will be made available for research purposes.</description><subject>Adenoma, Islet Cell - blood</subject><subject>C-Peptide - analogs &amp; derivatives</subject><subject>C-Peptide - blood</subject><subject>Diabetes Mellitus - blood</subject><subject>Humans</subject><subject>Pancreatic Neoplasms - blood</subject><subject>Peptides - blood</subject><subject>Proinsulin - blood</subject><subject>Quality Control</subject><subject>Radioimmunoassay - methods</subject><issn>0012-186X</issn><issn>1432-0428</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1980</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkEtLxDAURoMo4zi6cS9k5UKo5tW0XergqDDgxgF3JY8biDRNTdqF_94OM-jqcg-Hb3EQuqbknhJSPTxtCGElbag8QUsqOCuIYPUpWhJCWUFr-XmOLnL-IoTwUsgFWkgmyqbmS2R2GXB0WGETQ4g9zqPqrUoWu5j2bFDJ55nPju_z1Pker4sBhtFbwAFUnhIE6MeM9Q-23jlI84c7pWNSY0we8iU6c6rLcHW8K7TbPH-sX4vt-8vb-nFbGE7rsbBCM10JYrnhlTCyUdrVtBTMNpXhIEoKnDmjpDGaGWUlZaWzlTYzZlATvkK3h90hxe8J8tgGnw10neohTrmtSkoo53IW7w6iSTHnBK4dkg8q_bSUtPui7X_RWb45rk46gP1Tjwn5L6urce8</recordid><startdate>198003</startdate><enddate>198003</enddate><creator>Caygill, C P</creator><creator>Gaines Das, R E</creator><creator>Bangham, D R</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198003</creationdate><title>Use of a common standard for comparison of insulin C-peptide measurements by different laboratories</title><author>Caygill, C P ; Gaines Das, R E ; Bangham, D R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c318t-d4b2b740d3c374c69abf81542d97c3e451e32fca6ccb2cad6125fd7bce322e803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1980</creationdate><topic>Adenoma, Islet Cell - blood</topic><topic>C-Peptide - analogs &amp; derivatives</topic><topic>C-Peptide - blood</topic><topic>Diabetes Mellitus - blood</topic><topic>Humans</topic><topic>Pancreatic Neoplasms - blood</topic><topic>Peptides - blood</topic><topic>Proinsulin - blood</topic><topic>Quality Control</topic><topic>Radioimmunoassay - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Caygill, C P</creatorcontrib><creatorcontrib>Gaines Das, R E</creatorcontrib><creatorcontrib>Bangham, D R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Caygill, C P</au><au>Gaines Das, R E</au><au>Bangham, D R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of a common standard for comparison of insulin C-peptide measurements by different laboratories</atitle><jtitle>Diabetologia</jtitle><addtitle>Diabetologia</addtitle><date>1980-03</date><risdate>1980</risdate><volume>18</volume><issue>3</issue><spage>197</spage><epage>204</epage><pages>197-204</pages><issn>0012-186X</issn><eissn>1432-0428</eissn><abstract>A synthetic human C-peptide analogue has been used as a common standard for the comparison of insulin C-peptide measurements in seven assay systems in six laboratories. Even in terms of this common standard there was statistically significant numerical heterogeneity between laboratories for estimates of the C-peptide content of the same plasma samples. However, the consistency in ranking order of estimates of C-peptide in the plasma samples between laboratories suggests that laboratories are in most cases measuring at least similar immunoreactive constituents and that a reference plasma might prove useful in comparing results between laboratories. Until a more suitable reference material is available, the synthetic analogue, 64 formyllysine C-peptide, in ampoules coded 76/561, will be made available for research purposes.</abstract><cop>Germany</cop><pmid>6245983</pmid><doi>10.1007/BF00251916</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0012-186X
ispartof Diabetologia, 1980-03, Vol.18 (3), p.197-204
issn 0012-186X
1432-0428
language eng
recordid cdi_proquest_miscellaneous_75101336
source MEDLINE; SpringerNature Journals
subjects Adenoma, Islet Cell - blood
C-Peptide - analogs & derivatives
C-Peptide - blood
Diabetes Mellitus - blood
Humans
Pancreatic Neoplasms - blood
Peptides - blood
Proinsulin - blood
Quality Control
Radioimmunoassay - methods
title Use of a common standard for comparison of insulin C-peptide measurements by different laboratories
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T07%3A00%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20a%20common%20standard%20for%20comparison%20of%20insulin%20C-peptide%20measurements%20by%20different%20laboratories&rft.jtitle=Diabetologia&rft.au=Caygill,%20C%20P&rft.date=1980-03&rft.volume=18&rft.issue=3&rft.spage=197&rft.epage=204&rft.pages=197-204&rft.issn=0012-186X&rft.eissn=1432-0428&rft_id=info:doi/10.1007/BF00251916&rft_dat=%3Cproquest_cross%3E75101336%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75101336&rft_id=info:pmid/6245983&rfr_iscdi=true